Brief: BOD Australia To Commence Clinical Trial Into Effectiveness Of Medicinal Cannabis On Long-Covid
Jan 17 (Reuters) - BOD Australia Ltd BOD.AX :
* TO COMMENCE A CLINICAL TRIAL INTO EFFECTIVENESS OF
MEDICINAL
CANNABIS ON LONG-COVID
* SIX-MONTH CLINICAL TRIAL TO BE UNDERTAKEN IN COLLABORATION
WITH
DRUG SCIENCE UK
Source text for Eikon: ID:nASXbjnny3
Further company coverage: BOD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bod Science
See all newsBrief: Bod Science Says Adrian Sturrock To Step Down As CFO
Brief: Bod Science Executes Agreement To Acquire Issued Share Capital In Biortica Agrimed
Brief: Bod Science Announces Further Delay In Lodgement Of Appendix 4D & Half Year Report
Brief: Bod Science Says Now Entered Doca With Biortica In Accordance With Doca Proposal
Brief: Bod Science Announces Medicinal Cannabis Supply Agreement With Green Farmers Pty